Connected profiles2
Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Acromegaly peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Acromegaly. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
2 selected records.
Connected peptides
2 profiles.
Registry update years
2018–2019 in selected records.
Indication intelligence
Selected evidence landscape
Trial phases2
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 3 (1)Phase 2 (1)
Registry statuses1
Overall statuses at each retained observation, not necessarily current today.
Completed (2)
Across the connected peptide profiles, PeptideScanner also carries 105 selected PubMed records and 30 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Acromegaly unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT02217800
PeptideScanner retained ClinicalTrials.gov record NCT02217800 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was octreotide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- February 15, 2018
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT02493517
PeptideScanner retained ClinicalTrials.gov record NCT02493517 at 2026-07-30T20:57:18.712Z. Its registry update date was 2019-01-29, and PeptideScanner's reviewed identity mapping was lanreotide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- January 29, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Lanreotide · 2019-01-29
ClinicalTrials.gov record NCT02493517
Completed at the retained observation.
Open attributed record →Octreotide · 2018-02-15
ClinicalTrials.gov record NCT02217800
Completed at the retained observation.
Open attributed record →